{
    "title": "114_hr3952",
    "content": "The Act is titled the \"Congenital Heart Futures Reauthorization Act of 2015\" and amends the Public Health Service Act to establish a National Congenital Heart Disease Research, Surveillance, and Awareness system. The \"Congenital Heart Futures Reauthorization Act of 2015\" establishes a National Congenital Heart Disease Research, Surveillance, and Awareness system. The Act mandates the Secretary to enhance research and surveillance infrastructure for congenital heart disease, implement public outreach campaigns, and award grants for related activities. The Director of the Centers for Disease Control and Prevention is tasked with planning and executing a National Congenital Heart Disease Cohort Study to improve understanding of the disease's epidemiology. The \"Congenital Heart Futures Reauthorization Act of 2015\" mandates a National Congenital Heart Disease Research, Surveillance, and Awareness system to improve understanding of CHD epidemiology across the lifespan. This includes studying health care utilization, demographic factors, and outcome measures for CHD patients. The study may gather data on diverse populations and consider health disparities among those affected by CHD. The study mandated by the \"Congenital Heart Futures Reauthorization Act of 2015\" aims to improve understanding of CHD epidemiology, including health disparities and outcomes. Data generated from the study will be made public, while patient privacy regulations will be followed. Additionally, a Congenital Heart Disease Awareness Campaign will be implemented. The Director of the Centers for Disease Control and Prevention will establish an awareness campaign on Congenital Heart Disease (CHD) emphasizing its prevalence as the most common birth defect, highlighting its impact across the lifespan, and promoting specialized care for individuals with CHD. Collaboration and partnerships are permitted for the campaign. The awareness campaign on Congenital Heart Disease (CHD) will utilize collaborations with agencies, healthcare professionals, and patient advocacy organizations specializing in CHD. It will also involve the distribution of materials through various media channels. Entities eligible for grants must have specialized experience in CHD and submit an application to the Secretary. Authorization of appropriations is required to implement this section. Authorization of appropriations totaling $4,000,000 for each fiscal year from 2016 to 2020 is granted to carry out this section. SEC. 3. CONGENITAL HEART DISEASE RESEARCH. Amends Section 425 of the Public Health Service Act to focus on congenital heart disease. The Director of the Institute may expand research on congenital heart disease, including causation, long-term outcomes, diagnosis, treatment, prevention, and barriers to care for individuals with the condition. The Director of the Institute may coordinate research efforts on congenital heart disease among multiple institutions, consider minority and medically underserved communities, and provide a report to Congress on ongoing and future research plans. The Director of the Institute may coordinate research efforts on congenital heart disease among multiple institutions, consider minority and medically underserved communities, and provide a report to Congress on ongoing and future research plans, including identifying future research plans and areas of greatest need for such research."
}